We are live on ! Find out more
DS

Dudley & Shanley Portfolio holdings

AUM $662M
1-Year Est. Return 10.7%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+10.7%
3 Year Est. Return
+57.04%
5 Year Est. Return
+90.57%
10 Year Est. Return
+304.94%
AUM
$635M
AUM Growth
-$12.5M
Cap. Flow
-$42.1M
Cap. Flow %
-6.62%
Top 10 Hldgs %
55.25%
Holding
37
New
Increased
14
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$2M
2
DOX icon
Amdocs
DOX
+$1.75M
3
KRNT icon
Kornit Digital
KRNT
+$1.28M
4
ADI icon
Analog Devices
ADI
+$21.6K
5
AME icon
Ametek
AME
+$20K

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$25.8M
2
WPM icon
Wheaton Precious Metals
WPM
+$10.5M
3
FISV
Fiserv Inc
FISV
+$4.41M
4
AON icon
Aon
AON
+$1.99M
5
DCI icon
Donaldson
DCI
+$1.65M

Sector Composition

Rank Sector Weight
1 Financials 23.03%
2 Technology 18.35%
3 Industrials 17.45%
4 Materials 16.54%
5 Consumer Discretionary 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXE icon
26
NexGen Energy
NXE
$6.08B
$5.55M 0.87%
1,236,500
GRID
27
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$11.1B
$5.31M 0.84%
46,900
HEI icon
28
HEICO Corp
HEI
$50.8B
$5.22M 0.82%
19,550
MSFT icon
29
Microsoft
MSFT
$2.92T
$4.07M 0.64%
10,854
-700
-6% -$285K
GNRC icon
30
Generac Holdings
GNRC
$11.5B
$2.49M 0.39%
19,650
ORA icon
31
Ormat Technologies
ORA
$6.05B
$2.12M 0.33%
30,000
-900
-3% -$61K
PHO icon
32
Invesco Water Resources ETF
PHO
$2.05B
$2.11M 0.33%
32,780
ROP icon
33
Roper Technologies
ROP
$38.7B
$1.5M 0.24%
2,550
ENPH icon
34
Enphase Energy
ENPH
$4.79B
$422K 0.07%
6,800
OCUL icon
35
Ocular Therapeutix
OCUL
$1.85B
$119K 0.02%
16,200
WST icon
36
West Pharmaceutical
WST
$23.7B
-78,661
Closed -$25.8M

Similar funds

Dudley & Shanley's Q1 2025 Portfolio in Review

As of Q1 2025, Dudley & Shanley held 37 positions worth $635M, down 1.9% from $648M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Dudley & Shanley withdrew a net $42.1M in Q1 2025, closing 1 position and reducing 11 holdings. Its most notable exit was West Pharmaceutical, an estimated $25.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dudley & Shanley added an estimated $2M to Avantor.

  • Dudley & Shanley added most to Avantor in Q1 2025, an estimated $2M increase.
  • Dudley & Shanley's biggest Q1 2025 reduction was Wheaton Precious Metals, cutting an estimated $10.5M.
  • Dudley & Shanley fully exited West Pharmaceutical in Q1 2025, selling an estimated $25.8M.
  • Dudley & Shanley's ten largest holdings make up 55% of its $635M portfolio in Q1 2025.
  • Dudley & Shanley opened 0 new positions and closed 1 in Q1 2025.
  • Dudley & Shanley's portfolio value fell 1.9% quarter-over-quarter to $635M.

Based on Dudley & Shanley's 13F filing for Q1 2025, filed 9 Apr 2025.